investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors

Nathanael Schiander Gray

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

No posts

Related projects

Deborah Morrison

Regulation of Ras-Dependent Signal Transduction Pathways

Trachea, bronchus and lung

Eusebio Manchado-Robles

Drivers and dependencies as therapeutic targets in KRAS-mutant lung cancers

Trachea, bronchus and lung

Peter Kent Jackson

Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer

Trachea, bronchus and lung

James K Chen

Chemical genetic dissection of Hipk4-dependent Hedgehog pathway activation

Trachea, bronchus and lung

Tyshia Kyree Gwin

Induction of tumor suppressor p16INK4A by human papillomavirus 16 E7 oncoprotein

Trachea, bronchus and lung

Carlo M Croce

MiRNAs/UCRs: Biomarkers for Cancer Risk, Tumor Detection, Progression and Treatment

Trachea, bronchus and lung

Marc Nicklaus

In Silico Screening for Cancer Targets

Trachea, bronchus and lung

Pathology Hematology and hematologic malignancies

Stefan Posse

Early Detection of Response to Treatment in Cancer by Hyperpolarized Metabolic MR

Trachea, bronchus and lung

Pathology

Curtis Harris

p53, Aging, and Cancer

Trachea, bronchus and lung